PE20010825A1 - A PHARMACEUTICAL COMPOSITION THAT HAS GREAT PERMEABILITY THROUGH THE CELLULAR MEMBRANE - Google Patents
A PHARMACEUTICAL COMPOSITION THAT HAS GREAT PERMEABILITY THROUGH THE CELLULAR MEMBRANEInfo
- Publication number
- PE20010825A1 PE20010825A1 PE2000001154A PE0011542000A PE20010825A1 PE 20010825 A1 PE20010825 A1 PE 20010825A1 PE 2000001154 A PE2000001154 A PE 2000001154A PE 0011542000 A PE0011542000 A PE 0011542000A PE 20010825 A1 PE20010825 A1 PE 20010825A1
- Authority
- PE
- Peru
- Prior art keywords
- pth
- pharmaceutical composition
- cellular membrane
- composition
- great permeability
- Prior art date
Links
- 230000001413 cellular effect Effects 0.000 title 1
- 239000012528 membrane Substances 0.000 title 1
- 230000035699 permeability Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 5
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 5
- 239000000199 parathyroid hormone Substances 0.000 abstract 5
- 229960001319 parathyroid hormone Drugs 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- ZXKXJHAOUFHNAS-UHFFFAOYSA-N fenfluramine hydrochloride Chemical compound [Cl-].CC[NH2+]C(C)CC1=CC=CC(C(F)(F)F)=C1 ZXKXJHAOUFHNAS-UHFFFAOYSA-N 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 abstract 1
- 229960004622 raloxifene Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE a)HORMONA PARATIROIDEA (PTH); b)UN TENSIOACTIVO DE UN ACIDO DE ION BIPOLAR BETAINICO TAL COMO PROPILBETAINA, LAURAMIDOPROPILBETAINA; QUE AUMENTA LA BIODISPONIBILIDAD DE LA PTH SIENDO LA RELACION PONDERAL DE PTH A PROPILBETAINA DE 0,05:100 A 10:100 Y DE PTH A LAURAMIDOPROPILBETAINA ES DE 0,031:1 A 1:23. TAMBIEN SE REFIERE AL USO DE LA COMPOSICION CON RALOXIFENO EN FORMA SIMULTANEA, SECUENCIAL O DENTRO DE UN INTERVALO TERAPEUTICAMENTE EFICAZ. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA PERDIDA DE MASA OSEAIT REFERS TO A COMPOSITION INCLUDING a) PARATHYROID HORMONE (PTH); b) A TENSIOACTIVE OF A BIPOLAR ION BETAINIC ACID SUCH AS PROPILBETAINE, LAURAMIDOPROPILBETAINE; WHICH INCREASES THE BIOAVAILABILITY OF PTH BEING THE PONDERAL RATIO OF PTH TO PROPILBETAINE FROM 0.05: 100 TO 10: 100 AND OF PTH TO LAURAMIDOPROPILBETAINE IS FROM 0.031: 1 TO 1:23. IT ALSO REFERS TO THE USE OF THE COMPOSITION WITH RALOXIFENE SIMULTANEOUSLY, SEQUENTIAL OR WITHIN A THERAPEUTICALLY EFFECTIVE INTERVAL. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF LOSS OF BONE MASS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16255799P | 1999-10-29 | 1999-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010825A1 true PE20010825A1 (en) | 2001-08-13 |
Family
ID=22586144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001154A PE20010825A1 (en) | 1999-10-29 | 2000-10-27 | A PHARMACEUTICAL COMPOSITION THAT HAS GREAT PERMEABILITY THROUGH THE CELLULAR MEMBRANE |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1189301A (en) |
PE (1) | PE20010825A1 (en) |
WO (1) | WO2001032201A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002344371B2 (en) | 2001-06-01 | 2006-06-29 | Novartis Ag | Orally administering parathyroid hormone and calcitonin |
CA2782640A1 (en) | 2009-12-07 | 2011-06-16 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
CN118001411A (en) * | 2024-04-09 | 2024-05-10 | 深圳奥礼生物科技有限公司 | Intestinal tract absorption composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
JPH11292787A (en) * | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | Transucosal preparation containing physiologically active peptide |
DE19538687A1 (en) * | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stable pharmaceutical dosage forms containing parathyroid hormone |
-
2000
- 2000-10-16 AU AU11893/01A patent/AU1189301A/en not_active Abandoned
- 2000-10-16 WO PCT/US2000/026257 patent/WO2001032201A2/en active Application Filing
- 2000-10-27 PE PE2000001154A patent/PE20010825A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1189301A (en) | 2001-05-14 |
WO2001032201A2 (en) | 2001-05-10 |
WO2001032201A3 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992068L (en) | Microemulsion and process for its preparation | |
ATE83374T1 (en) | NEW GALENIC FORM OF FENOFIBRATE. | |
SE0002102D0 (en) | Chemical compound | |
HUT43637A (en) | Process for producing biologically active new materials and veterinary compositions containing them as active agents, and nematocide insecticide and acaricide compositions containing the above mentioned materials as active agents | |
ES2195970T3 (en) | L-RIBAVIRINA AND USES OF THE SAME. | |
ATE257813T1 (en) | FOAM CERAMIC | |
ES2221950T3 (en) | DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS. | |
ES2173378T3 (en) | MICROPOROUS CRYSTAL MATERIAL, PROCEDURE FOR PREPARATION AND USE IN DETERGENT COMPOSITIONS. | |
TR199900548A3 (en) | Production of dosage units using low shear granulation. | |
PE20010825A1 (en) | A PHARMACEUTICAL COMPOSITION THAT HAS GREAT PERMEABILITY THROUGH THE CELLULAR MEMBRANE | |
ITRM910430A1 (en) | PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN WITH IMPROVED ABSORPTION, THEIR PREPARATION AND THEIR USE | |
EA199800553A1 (en) | POWDER RECOVER AND METHOD FOR ITS PREPARATION | |
EA199900750A1 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION, INCLUDING THE ACTIVE INGREDIENT, IN THE HIGHEST DEGREE IN THE WATER | |
ES2101334T3 (en) | THERAPEUTIC USE OF FOSFORIL-L-SERINA-N-ACIL-SPHINGOSIN. | |
WO2002024181A3 (en) | The use of melatonin for induction of general anesthesia | |
DE69914327D1 (en) | BIOLOGICALLY ACTIVE MICRODISPERSION COMPOSITION | |
BRPI0000967A (en) | processes for preparing growth hormone secretagogue compounds | |
IT1303759B1 (en) | IMPROVED PROCEDURE FOR THE PREPARATION OF 7-AZAINDOLYL-3-CARBOXYLIC ACID. | |
HRP20031068A2 (en) | Chloromethylation of thiophene | |
ZA200000578B (en) | Process for the preparation of organic azides. | |
EA200200211A1 (en) | PHARMACEUTICAL COMPOSITION AND ITS PREPARATION | |
ES2160085B1 (en) | OXYM Erythromycin Dihydride | |
AR025740A1 (en) | PROCEDURE FOR THE IDENTIFICATION OF AT LEAST AN ACTIVE CHEMICAL SUBSTANCE IN A MIXTURE OF ACTIVE AND INACTIVE SUBSTANCES WITH RELATIVE MOLAR MASSES OF 150 TO 30,000 | |
MX9603133A (en) | Parahydrophenylacetic acid for insecticide repellency reduction. | |
ITRM930686A0 (en) | USE OF ALTRENOGEST FOR THE PREPARATION OF INJECTABLE VETERINARY COMPOSITIONS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |